CHENNAI: Caplin Point Laboratories Limited has announced that Caplin Steriles Limited, a wholly owned subsidiary of Caplin Point Laboratories Ltd, has entered into a license and supply agreement with Baxter Healthcare Corporation for five generic injectable ANDAs.
Commenting on the transaction, C.C.Paarthipan, Chairman, Caplin Point Laboratories Limited, said: “We’re glad to enhance our partnership with Baxter with this agreement. All these ANDAs have been developed in-house, and we’re keen to license them to Baxter, who have an excellent sales and marketing infrastructure in the US for commercialization of these products.”
Specific terms of the agreement were not disclosed.[the_ad id=”31605″]